These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20740332)

  • 1. Tablet splitting of a narrow therapeutic index drug: a case with levothyroxine sodium.
    Shah RB; Collier JS; Sayeed VA; Bryant A; Habib MJ; Khan MA
    AAPS PharmSciTech; 2010 Sep; 11(3):1359-67. PubMed ID: 20740332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose Uniformity of Scored and Unscored Tablets: Application of the FDA Tablet Scoring Guidance for Industry.
    Ciavarella AB; Khan MA; Gupta A; Faustino PJ
    PDA J Pharm Sci Technol; 2016 11/12; 70(6):523-532. PubMed ID: 27974592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications.
    Hill SW; Varker AS; Karlage K; Myrdal PB
    J Manag Care Pharm; 2009 Apr; 15(3):253-61. PubMed ID: 19326956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levothyroxine Sodium Pentahydrate Tablets - Formulation Considerations.
    Kaur N; Suryanarayanan R
    J Pharm Sci; 2021 Dec; 110(12):3743-3756. PubMed ID: 34384799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the Influence of Excipients on the Stability of Levothyroxine Sodium Pentahydrate.
    Kaur N; Suryanarayanan R
    Mol Pharm; 2021 Jul; 18(7):2683-2693. PubMed ID: 34061524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tablet splitting: is it worthwhile? Analysis of drug content and weight uniformity for half tablets of 16 commonly used medications in the outpatient setting.
    Helmy SA
    J Manag Care Spec Pharm; 2015 Jan; 21(1):76-86. PubMed ID: 25562775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions.
    Svirskis D; Lin SW; Brown H; Sangaroomthong A; Shin D; Wang Z; Xu H; Dean R; Vareed P; Jensen M; Wu Z
    Int J Pharm Compd; 2018; 22(2):164-171. PubMed ID: 29877863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A "Large-N" Content Uniformity Process Analytical Technology (PAT) Method for Phenytoin Sodium Tablets.
    Pawar P; Talwar S; Reddy D; Bandi CK; Wu H; Sowrirajan K; Friedman R; Drazer G; Drennen JK; Muzzio FJ
    J Pharm Sci; 2019 Jan; 108(1):494-505. PubMed ID: 30009795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Discrepancy between the European Pharmacopoeia Test and an Adopted United States Pharmacopoeia Test Regarding the Weight Uniformity of Scored Tablet Halves: Is Harmonization Required?
    Zaid AN; Ghoush AA; Al-Ramahi R; Are'r M
    PDA J Pharm Sci Technol; 2012; 66(1):20-7. PubMed ID: 22307659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Certain Pharmaceutical Quality Attributes of Lisinopril Split Tablets.
    Fahelelbom KM; Al-Tabakha MM; Eissa NA; Javadi J
    Sci Pharm; 2016 Oct; 84(4):646-653. PubMed ID: 27727195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of tablet splitting: Comparison study between hand splitting and tablet cutter.
    Habib WA; Alanizi AS; Abdelhamid MM; Alanizi FK
    Saudi Pharm J; 2014 Nov; 22(5):454-9. PubMed ID: 25473334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of tablet splitting and liquid measurements: an examination of who, what and how.
    Abu-Geras D; Hadziomerovic D; Leau A; Khan RN; Gudka S; Locher C; Razaghikashani M; Lim LY
    J Pharm Pharmacol; 2017 May; 69(5):603-612. PubMed ID: 28028813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of an extemporaneously compounded levothyroxine sodium oral liquid.
    Boulton DW; Fawcett JP; Woods DJ
    Am J Health Syst Pharm; 1996 May; 53(10):1157-61. PubMed ID: 8734676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tablet splitting and weight uniformity of half-tablets of 4 medications in pharmacy practice.
    Tahaineh LM; Gharaibeh SF
    J Pharm Pract; 2012 Aug; 25(4):471-6. PubMed ID: 22544621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidating the Splitting Behavior of Tablets to Optimize the Pharmacotherapy in Veterinary Medicine.
    Bedogni GR; Pires FQ; Chaker JA; Sa-Barreto LL; Seremeta K; Okulik N; Salomon CJ; Cunha-Filho M
    AAPS PharmSciTech; 2021 Feb; 22(2):67. PubMed ID: 33554316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of excipients on the stability of levothyroxine sodium pentahydrate tablets.
    Patel H; Stalcup A; Dansereau R; Sakr A
    Int J Pharm; 2003 Oct; 264(1-2):35-43. PubMed ID: 12972334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of batch age on potency and dissolution of levothyroxine sodium tablets: impact of BP and USP monograph differences on dissolution results.
    Abou-Taleb BA; Nounou MI; Khalafallah N; Khalil S
    Drug Dev Ind Pharm; 2018 Nov; 44(11):1762-1769. PubMed ID: 29973090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tablet splitting: Product quality assessment of metoprolol succinate extended release tablets.
    Zhao N; Zidan A; Tawakkul M; Sayeed VA; Khan M
    Int J Pharm; 2010 Nov; 401(1-2):25-31. PubMed ID: 20849940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the content uniformity of a low-dose tablet formulation through roller compaction optimization.
    am Ende MT; Moses SK; Carella AJ; Gadkari RA; Graul TW; Otano AL; Timpano RJ
    Pharm Dev Technol; 2007; 12(4):391-404. PubMed ID: 17763144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability in tablet fragment weights when splitting unscored cyclobenzaprine 10 mg tablets.
    Cook TJ; Edwards S; Gyemah C; Shah M; Shah I; Fox T
    J Am Pharm Assoc (2003); 2004; 44(5):583-6. PubMed ID: 15496044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.